Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
5.05
+0.09 (1.81%)
May 20, 2025, 12:44 PM CST
SHE:300289 Revenue
Beijing Leadman Biochemistry had revenue of 78.91M CNY in the quarter ending March 31, 2025, a decrease of -16.61%. This brings the company's revenue in the last twelve months to 354.51M, down -20.87% year-over-year. In the year 2024, Beijing Leadman Biochemistry had annual revenue of 370.23M, down -19.79%.
Revenue (ttm)
354.51M
Revenue Growth
-20.87%
P/S Ratio
7.61
Revenue / Employee
757.50K
Employees
468
Market Cap
2.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 370.23M | -91.33M | -19.79% |
Dec 31, 2023 | 461.55M | -244.42M | -34.62% |
Jan 1, 2023 | 705.98M | 141.92M | 25.16% |
Jan 1, 2022 | 564.06M | 92.55M | 19.63% |
Dec 31, 2020 | 471.51M | -43.63M | -8.47% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |